Name: BPC-157 / TB-500
Brand: Argo Peptides
SKU: ARG-BPC-157-TB-500-20MG
Price: 119.00 USD
Availability: InStock

Question 1

What exactly are BPC-157 and TB-500, and why combine them?

Accepted Answer

BPC-157 is a synthetic peptide derived from a protein found in gastric juice, and TB-500 is a lab-made version of thymosin beta-4, a naturally occurring peptide. Researchers combine them because they appear to support tissue repair through different mechanisms — BPC-157 more toward blood-vessel growth and gut protection, TB-500 toward cell migration and reduced scarring. The 20 mg vial holds 10 mg of each for convenience in comparative repair studies.

Question 2

What has research actually shown about these peptides?

Accepted Answer

In rodent injury models, BPC-157 has been linked to faster tendon, muscle and gut healing and new blood-vessel formation, while TB-500 (thymosin beta-4) has been studied for driving cell migration and cutting scar tissue in wound models. These findings come from animal and cell studies, not human trials. They point to why the pair is a popular subject in preclinical recovery research.

Question 3

Are BPC-157 or TB-500 FDA approved?

Accepted Answer

No. Neither BPC-157 nor TB-500 is approved by the FDA for any use, and there is no approved drug based on them. The material sold here is a research chemical supplied strictly for in-vitro and laboratory research use only — not for human or veterinary use.

Question 4

How is this combo used in research settings versus the peptides alone?

Accepted Answer

Some researchers use the co-lyophilised vial to study whether the two peptides show additive or complementary effects on tissue repair compared to running each one separately. Because both target different steps of the healing process, the combination is a common design choice in preclinical models. Each component's assayed content is stated on the lot's certificate of analysis.

Question 5

What is the molecular structure of the two peptides?

Accepted Answer

BPC-157 is a 15-amino-acid peptide with the molecular formula C62H98N16O22 and a molecular weight of about 1419.5 g/mol. TB-500 corresponds to the active fragment region of thymosin beta-4, a 43-residue peptide with a molecular weight near 4963 g/mol whose key feature is an actin-binding domain. Identity for each lot is confirmed by LC-MS.

BPC-157 / TB-500

Every vial ships with its own report

How BPC-157 / TB-500 works

AngiogenesisVEGFR2 pathway

Cell migrationactin binding

Gut integritycytoprotection

Every batch we've tested

What the studies found

What buyers say

Common questions

99.88% pure, or your money back.

Popular right now

Search